This is a preview of subscription content, log in via an institution to check access.
References
Ritchlin CT, Daikh BE: Recent advances in the treatment of the seronegative spondyloarthropathies. Curr Rheumatol Rep 2001, 3:399–403.
Braun J, Brandt J, Listing J, et al.: Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet 2002, 359:1187–1193.
Gorman JD, Sack KE, Davis JC Jr.: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha [comment]. N Engl J Med 2002, 346:1349–1356.
Braun J, Baraliakos X, Golder W, et al.: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003, 48:1126–1136.
Marzo-Ortega H, McGonagle D, O’Connor P, Emery P: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study [comment]. Arthritis Rheum 2001, 44:2112–2117.
Rights and permissions
About this article
Cite this article
Ritchlin, C.T. Treatment guidelines for ankylosing spondylitis. Curr Rheumatol Rep 6, 96–97 (2004). https://doi.org/10.1007/s11926-004-0052-x
Issue Date:
DOI: https://doi.org/10.1007/s11926-004-0052-x